General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Acasti to Participate in Upcoming San Francisco Investor Conferences in January 2024 | globenewswire.com • |
Acasti to Participate in the H.C. Wainwright Global Investment Conference | globenewswire.com • |
Acasti to Present GTX-104 Pharmacokinetic Comparison Data at Neurocritical Care Annual Meeting | globenewswire.com • |
Has Acasti Pharma (ACST) Outpaced Other Medical Stocks This Year? | zacks.com • |
Acasti Pharma Inc. (ACST) Q3 2023 Earnings Call Transcript | seekingalpha.com • |
Acasti Pharma to Present at Lytham Partners Investor Select Conference on January 31 | globenewswire.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-06-28 | 2024-03 | -0.35 | N/A | N/A | N/A |
2024-02-12 | 2023-12 | -0.3 | -0.21 | 0.09 | 30.00% |
2023-11-13 | 2023-09 | -0.29 | -0.19 | 0.1 | 34.48% |
2023-08-11 | 2023-06 | -0.63 | -0.34 | 0.29 | 46.03% |
2023-06-23 | 2023-03 | -0.78 | -0.3 | 0.48 | 61.54% |
2023-02-14 | 2022-12 | -0.78 | -0.54 | 0.24 | 30.77% |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2022-09-08 | Kohli (Prashant) | Senior Officer of Issuer | 128.14K | Opening Balance-Initial SEDI Report |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Renaissance Technologies, LLC | 11.27K | 35.50K | 0.15% |
2023-06-29 | Geode Capital Management, LLC | 3.06K | 9.63K | 0.04% |
2023-09-29 | National Bank of Canada/FI | 2.90K | 8.07K | 0.04% |
2023-06-29 | Jane Street Group, LLC | 2.37K | 7.46K | 0.03% |
2023-06-29 | Morgan Stanley | 1.88K | 5.93K | 0.03% |
2023-06-29 | Two Sigma Securities, LLC | 2.52K | 7.92K | 0.03% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-05-30 | Fidelity NASDAQ Composite Index Fund | 3.06K | 9.91K | 0.04% |
Split | Date |
---|---|
1 : 6 | 2023-07-10 |
1 : 8 | 2021-08-31 |
1 : 10 | 2015-10-15 |
1 : 10 | 2015-10-14 |
$ACST 12k shares $1.14, average down 0.65
$ACST don’t get discouraged. Hang in there, it will payoff
$ACST Realistically, a company with enough cash on hand, no debt had ever gone to bankruptcy? They know how valuable the company is and won’t risk to get delisted. Wait and see.
$ACST calm down folks. The management have to say something anyway regarding all the money they raised from offering plus what they intend to do after telling us of strategic alternatives. Wait, they are obliged to.
$ACST stable and steady. Faith
$ACST go go go! Send it up!
$ACST news by Monday April 12th